Naber TH - Search Results

1

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.

Netea MG, Ferwerda G, de Jong DJ, Jansen T, Jacobs L, Kramer M, Naber TH, Drenth JP, Girardin SE, Kullberg BJ, Adema GJ, Van der Meer JW. Netea MG, et al. Among authors: naber th. J Immunol. 2005 May 15;174(10):6518-23. doi: 10.4049/jimmunol.174.10.6518. J Immunol. 2005. PMID: 15879155

2

NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.

Netea MG, Kullberg BJ, de Jong DJ, Franke B, Sprong T, Naber TH, Drenth JP, Van der Meer JW. Netea MG, et al. Among authors: naber th. Eur J Immunol. 2004 Jul;34(7):2052-9. doi: 10.1002/eji.200425229. Eur J Immunol. 2004. PMID: 15214053 Free article.

3

Side effects of azathioprine in patients with Crohn's disease.

de Jong DJ, Goullet M, Naber TH. de Jong DJ, et al. Among authors: naber th. Eur J Gastroenterol Hepatol. 2004 Feb;16(2):207-12. doi: 10.1097/00042737-200402000-00014. Eur J Gastroenterol Hepatol. 2004. PMID: 15075996

4

Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans.

Wanten GJ, Netea MG, Naber TH, Curfs JH, Jacobs LE, Verver-Jansen TJ, Kullberg BJ. Wanten GJ, et al. Among authors: naber th. Infect Immun. 2002 Nov;70(11):6471-4. doi: 10.1128/IAI.70.11.6471-6474.2002. Infect Immun. 2002. PMID: 12379731 Free PMC article. Clinical Trial.

5

Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.

de Jong DJ, Bac DJ, Tan G, de Boer SY, Grabowsky IL, Jansen JB, Greinwald R, Naber TH. de Jong DJ, et al. Among authors: naber th. Neth J Med. 2007 Oct;65(9):339-45. Neth J Med. 2007. PMID: 17954953 Free article. Clinical Trial.

6

A functional interleukin-10 mutation in Dutch patients with Crohn's disease.

van der Linde K, Boor PP, van Bodegraven AA, de Jong DJ, Crusius JB, Naber TH, Kuipers EJ, Wilson JH, de Rooij FW. van der Linde K, et al. Among authors: naber th. Dig Liver Dis. 2005 May;37(5):330-5. doi: 10.1016/j.dld.2004.12.009. Dig Liver Dis. 2005. PMID: 15843082

7

Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase.

de Jong DJ, van der Logt EM, van Schaik A, Roelofs HM, Peters WH, Naber TH. de Jong DJ, et al. Among authors: naber th. Gut. 2003 Apr;52(4):547-51. doi: 10.1136/gut.52.4.547. Gut. 2003. PMID: 12631667 Free PMC article.

8

Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn's disease.

Brouwers AH, De Jong DJ, Dams ET, Oyen WJ, Boerman OC, Laverman P, Naber TH, Storm G, Corstens FH. Brouwers AH, et al. Among authors: naber th. J Drug Target. 2000;8(4):225-33. doi: 10.3109/10611860008997901. J Drug Target. 2000. PMID: 11144233 Clinical Trial.

9

No genetic association between EPHX1 and Crohn's disease.

Peters WH, van der Logt EM, Te Morsche RH, Roelofs HM, de Jong DJ, Naber TH. Peters WH, et al. Among authors: naber th. Gut. 2005 Nov;54(11):1659-60. doi: 10.1136/gut.2005.076422. Epub 2005 Jul 19. Gut. 2005. PMID: 16030175 Free PMC article. No abstract available.

10

Murine TNF(DeltaARE) Crohn's disease model displays diminished expression of intestinal Ca2+ transporters.

Huybers S, Apostolaki M, van der Eerden BC, Kollias G, Naber TH, Bindels RJ, Hoenderop JG. Huybers S, et al. Among authors: naber th. Inflamm Bowel Dis. 2008 Jun;14(6):803-11. doi: 10.1002/ibd.20385. Inflamm Bowel Dis. 2008. PMID: 18266230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters